Total Payments
$100,290
2024 Payments
$133.86
Companies
15
Transactions
103
Medicare Patients
826
Medicare Billing
$202,481
Payment Breakdown by Category
Other$83,285 (83.0%)
Travel$14,309 (14.3%)
Food & Beverage$2,677 (2.7%)
Education$19.69 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $73,745 | 26 | 73.5% |
| Travel and Lodging | $14,309 | 29 | 14.3% |
| Honoraria | $9,540 | 3 | 9.5% |
| Food and Beverage | $2,677 | 44 | 2.7% |
| Education | $19.69 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | $87,339 | 67 | $0 (2023) |
| Horizon Therapeutics plc | $11,063 | 10 | $0 (2022) |
| Roche Products Limited | $1,134 | 3 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $182.00 | 3 | $0 (2024) |
| Lilly USA, LLC | $136.78 | 9 | $0 (2021) |
| Allergan, Inc. | $114.32 | 1 | $0 (2020) |
| OPKO Pharmaceuticals, LLC | $111.30 | 1 | $0 (2019) |
| NxStage Medical, Inc. | $61.02 | 1 | $0 (2017) |
| ABIOMED | $41.38 | 1 | $0 (2024) |
| GlaxoSmithKline, LLC. | $31.03 | 2 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $133.86 | 2 | AstraZeneca Pharmaceuticals LP ($92.48) |
| 2023 | $5,159 | 6 | Bayer Healthcare Pharmaceuticals Inc. ($4,024) |
| 2022 | $72,814 | 58 | Bayer HealthCare Pharmaceuticals Inc. ($66,204) |
| 2021 | $20,244 | 22 | Bayer HealthCare Pharmaceuticals Inc. ($17,110) |
| 2020 | $1,569 | 3 | Horizon Therapeutics plc ($1,440) |
| 2019 | $206.84 | 4 | OPKO Pharmaceuticals, LLC ($111.30) |
| 2018 | $87.55 | 6 | Lilly USA, LLC ($58.67) |
| 2017 | $75.79 | 2 | NxStage Medical, Inc. ($61.02) |
All Payment Transactions
103 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/12/2024 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $92.48 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/12/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $41.38 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/15/2023 | Roche Products Limited | Gazyva (Biological) | Food and Beverage | In-kind items and services | $469.94 | General |
| Category: BioOncology | ||||||
| 07/15/2023 | Roche Products Limited | Gazyva (Biological) | Travel and Lodging | In-kind items and services | $383.91 | General |
| Category: BioOncology | ||||||
| 07/15/2023 | Roche Products Limited | Gazyva (Biological) | Travel and Lodging | In-kind items and services | $280.59 | General |
| Category: BioOncology | ||||||
| 05/02/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,330.00 | General |
| Category: Cardio-renal | ||||||
| 05/01/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Travel and Lodging | In-kind items and services | $628.75 | General |
| Category: Cardio-renal | ||||||
| 04/28/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $65.57 | General |
| Category: Cardio-renal | ||||||
| 12/07/2022 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Education | In-kind items and services | $19.69 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 11/14/2022 | Horizon Therapeutics plc | PROCYSBI (Drug) | Honoraria | Cash or cash equivalent | $5,040.00 | General |
| Category: PROCYSBI | ||||||
| 11/14/2022 | Horizon Therapeutics plc | PROCYSBI (Drug) | Travel and Lodging | Cash or cash equivalent | $941.19 | General |
| Category: PROCYSBI | ||||||
| 11/14/2022 | Horizon Therapeutics plc | PROCYSBI (Drug) | Travel and Lodging | Cash or cash equivalent | $292.67 | General |
| Category: PROCYSBI | ||||||
| 11/14/2022 | Horizon Therapeutics plc | PROCYSBI (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: PROCYSBI | ||||||
| 11/14/2022 | Horizon Therapeutics plc | PROCYSBI (Drug) | Food and Beverage | In-kind items and services | $64.99 | General |
| Category: PROCYSBI | ||||||
| 11/14/2022 | Horizon Therapeutics plc | PROCYSBI (Drug) | Food and Beverage | In-kind items and services | $49.99 | General |
| Category: PROCYSBI | ||||||
| 11/14/2022 | Horizon Therapeutics plc | PROCYSBI (Drug) | Food and Beverage | In-kind items and services | $24.99 | General |
| Category: PROCYSBI | ||||||
| 11/14/2022 | Horizon Therapeutics plc | PROCYSBI (Drug) | Food and Beverage | In-kind items and services | $24.36 | General |
| Category: PROCYSBI | ||||||
| 10/25/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,805.00 | General |
| Category: Cardio-renal | ||||||
| 09/20/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $14.77 | General |
| Category: NEUROSCIENCE | ||||||
| 08/18/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Travel and Lodging | In-kind items and services | $188.00 | General |
| Category: Cardio-renal | ||||||
| 08/18/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Travel and Lodging | In-kind items and services | $24.00 | General |
| Category: Cardio-renal | ||||||
| 08/18/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $22.75 | General |
| Category: Cardio-renal | ||||||
| 08/18/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $10.54 | General |
| Category: Cardio-renal | ||||||
| 05/12/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,550.00 | General |
| Category: Cardio-renal | ||||||
| 05/11/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $90.64 | General |
| Category: Cardio-renal | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 124 | 172 | $82,043 | $16,437 |
| 2022 | 9 | 234 | 408 | $206,361 | $44,751 |
| 2021 | 9 | 209 | 452 | $256,468 | $58,711 |
| 2020 | 12 | 259 | 577 | $444,092 | $82,582 |
Total Patients
826
Total Services
1,609
Medicare Billing
$202,481
Procedure Codes
38
All Medicare Procedures & Services
38 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2023 | 15 | 38 | $41,344 | $8,564 | 20.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 32 | 39 | $14,040 | $2,635 | 18.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 44 | 53 | $12,985 | $2,158 | 16.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 21 | 30 | $7,770 | $1,858 | 23.9% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 12 | 12 | $5,904 | $1,222 | 20.7% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2022 | 16 | 62 | $66,931 | $14,514 | 21.7% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2022 | 13 | 41 | $53,507 | $11,589 | 21.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 45 | 64 | $17,755 | $4,194 | 23.6% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 45 | 74 | $18,542 | $4,132 | 22.3% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2022 | 32 | 54 | $16,128 | $3,062 | 19.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 44 | 52 | $10,124 | $2,461 | 24.3% |
| 90945 | Dialysis procedure including 1 evaluation | Facility | 2022 | 12 | 29 | $9,480 | $1,955 | 20.6% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 16 | 21 | $7,635 | $1,682 | 22.0% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 11 | 11 | $6,259 | $1,161 | 18.5% |
| 90966 | Home dialysis services per month, patient 20 years of age or older | Office | 2021 | 11 | 102 | $108,834 | $24,226 | 22.3% |
| 90960 | Dialysis services (4 or more physician visits per month), patient 20 years of age and older | Office | 2021 | 11 | 30 | $38,910 | $8,622 | 22.2% |
| 90961 | Dialysis services (2-3 physician visits per month), patient 20 years of age and older | Office | 2021 | 12 | 31 | $33,077 | $7,371 | 22.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 56 | 76 | $15,884 | $5,431 | 34.2% |
| 90935 | Hemodialysis procedure with one physician evaluation | Facility | 2021 | 31 | 64 | $20,160 | $3,730 | 18.5% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 34 | 62 | $15,066 | $3,536 | 23.5% |
| 90945 | Dialysis procedure including one evaluation | Facility | 2021 | 13 | 40 | $13,200 | $2,647 | 20.1% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 17 | 23 | $8,073 | $1,885 | 23.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 24 | 24 | $3,264 | $1,262 | 38.7% |
| 90960 | Dialysis services (4 or more physician visits per month), patient 20 years of age and older | Office | 2020 | 23 | 84 | $108,948 | $18,712 | 17.2% |
| 90966 | Home dialysis services per month, patient 20 years of age or older | Office | 2020 | 11 | 73 | $77,891 | $13,959 | 17.9% |
About Dr. Umar Farooq, M.D
Dr. Umar Farooq, M.D is a Nephrology healthcare provider based in Hershey, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/24/2007. The National Provider Identifier (NPI) number assigned to this provider is 1972796621.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Umar Farooq, M.D has received a total of $100,290 in payments from pharmaceutical and medical device companies, with $133.86 received in 2024. These payments were reported across 103 transactions from 15 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($73,745).
As a Medicare-enrolled provider, Farooq has provided services to 826 Medicare beneficiaries, totaling 1,609 services with total Medicare billing of $202,481. Data is available for 4 years (2020–2023), covering 38 distinct procedure/service records.
Ad
Practice Information
- Specialty Nephrology
- Other Specialties Internal Medicine
- Location Hershey, PA
- Active Since 08/24/2007
- Last Updated 01/13/2012
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1972796621
Products in Payments
- Kerendia (Drug) $87,339
- PROCYSBI (Drug) $11,063
- Gazyva (Biological) $1,134
- TRULICITY (Drug) $123.60
- UBRELVY (Drug) $114.32
- Rayaldee (Drug) $111.30
- LOKELMA (Drug) $92.48
- FARXIGA (Drug) $89.52
- System One (Device) $61.02
- Impella (Device) $41.38
- LUPKYNIS (Drug) $19.69
- BEXSERO (Biological) $16.27
- QULIPTA (Drug) $14.77
- Renal - PD (Device) $14.77
- SHINGRIX (Biological) $14.76
- Utibron (Drug) $14.12
- BASAGLAR (Drug) $13.18
- Vascepa (Drug) $12.55
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Hershey
Navin Verma, Md, MD
Nephrology — Payments: $5,937
Nephrology $5,937
Vaqar Shah, Md, MD
Nephrology — Payments: $1,735
Nephrology $1,735
Ms. Amanda Karasinski, Md, MD
Nephrology — Payments: $1,568
Nephrology $1,568
Dr. Naman Trivedi, Md, MD
Nephrology — Payments: $622.27
Nephrology $622.27
Ronald Miller, Md, MD
Nephrology — Payments: $384.62
Nephrology $384.62
Nasrollah Ghahramani, Md, MD
Nephrology — Payments: $342.65
Nephrology $342.65